MK-8262

potential best-in-class CETP inh. (<1 mg QD)

completed Ph. I in HV; discont. as backup

from anacetrapib

Journal of Medicinal Chemistry

Merck & Co., Kenilworth, NJ, USA

The Merck CETP inhibitor backup, MK-8262, is potential best-in-class CETP inhibitor, which was only discontinued as a backup due to the success of its predecessor, anacetrapib in Ph. III. Reviewer Kim…

become a member to continue reading

Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.

Stay up-to-date and save more time with exclusive members-only content
On-board new team members with educational content and case studies

Generate ideas and discussion with easy-to-read slide decks
Generate ideas and discussion with easy-to-read slide decks